Phase 2 NAFLD Clinical Trials
6 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–6 of 6 trials
Recruiting
Phase 2
Randomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Gain After Liver Transplant
NAFLD
University of Virginia50 enrolled1 locationNCT05424003
Recruiting
Phase 2
Digoxin In NASH (CODIN)
MASLDMASH - Metabolic Dysfunction-Associated SteatohepatitisFatty Liver Disease+5 more
Yale University144 enrolled2 locationsNCT06588699
Recruiting
Phase 2
Milk Thistle Clinical Trial in Pediatric NAFLD
Non-alcoholic Fatty Liver Disease NAFLD
University Hospitals Cleveland Medical Center20 enrolled1 locationNCT06477146
Recruiting
Phase 2
A Trial to Evaluate the Efficacy, Safety, PK, and PD of HP515 in Non - Alcoholic Fatty Liver Disease ( NASH/MASH )
NAFLD - Non-Alcoholic Fatty Liver Disease
Hinova Pharmaceuticals Inc.80 enrolled2 locationsNCT07308548
Recruiting
Phase 2
Study of the Efficacy and Safety of Nicotinamide in Patients With Liver Fibrosis (NICOFIB)
ObesityNAFLDFatty Liver+3 more
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau30 enrolled1 locationNCT06599918
Recruiting
Phase 2
Effect of CoQ10 on the Outcome of MAFLD Patients
NAFLDFatty Liver
Ain Shams University60 enrolled1 locationNCT05984745